Encinitas, CA, United States of America

Max N Moore

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 2003-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Max N Moore. Retrieved from https://idiyas.com/inventor/max-n-moore

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0


Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 170(Granted Patents)


Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Max N Moore: Pioneering Oligonucleotide Synthesis

Introduction: Max N Moore, an accomplished inventor based in Encinitas, California, is known for his significant contributions to the field of biotechnology, particularly in oligonucleotide synthesis. With a total of four patents to his name, Moore’s work has advanced methods and apparatuses that facilitate the efficient production of oligonucleotides, which are crucial for various applications in medical and genetic research.

Latest Patents: Among his latest innovations, Moore has developed an "Apparatus for synthesizing oligonucleotides and methods of use." This invention involves an adjustable reaction zone with a variable volume, regulated by a piston to manage the headspace above the solid support during synthesis. He also holds a patent for "Oligonucleotide synthesis with alternative solvents," which details a method of manufacturing oligonucleotides incorporating a pentavalent phosphate triester. This method emphasizes the use of a 5' blocked-nucleoside and includes unique steps such as utilizing specific solvent washes, notably toluene, to enhance the synthesis process.

Career Highlights: Moore’s career has been prominently linked to Isis Pharmaceuticals, Inc., a leader in biopharmaceuticals focused on innovative drug development. His work at the company underscores his role as a key innovator in biotechnology. Throughout his tenure, he has dedicated himself to advancing techniques for oligonucleotide synthesis, contributing to the broader field of genetic research and therapeutics.

Collaborations: Max N Moore has collaborated with several talented professionals including Anthony Scozzari and Mark Andrade. Together, they have worked on various projects that have furthered the understanding and application of oligonucleotides in scientific research.

Conclusion: Through his inventive spirit and dedication to research, Max N Moore has made a substantial impact on the field of oligonucleotide synthesis. His patented technologies not only showcase his ingenuity but also hold promise for enhancing biotechnological applications in medicine and research. As his career continues, the innovations brought forth by Moore will likely inspire future advancements in the biotechnology landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…